🇺🇸 FDA
Patent

US 11078168

Substituted N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase

granted A61KA61K45/06A61P

Quick answer

US patent 11078168 (Substituted N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase) held by Phenex Discovery Verwaltungs-GmbH expires Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Phenex Discovery Verwaltungs-GmbH
Grant date
Tue Aug 03 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K45/06, A61P, A61P35/00